What does ORIC Pharmaceuticals, Inc. do?
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage product candidates include enozertinib formerly known as ORIC-114, a brain penetrant orally…
What is ORIC Pharmaceuticals, Inc.'s P/E and P/B ratio?
ORIC Pharmaceuticals, Inc. has a P/E ratio of -10.3 and a P/B ratio of 3.71.
What is ORIC Pharmaceuticals, Inc.'s debt-to-equity ratio?
ORIC Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.02.
How much does ORIC Pharmaceuticals, Inc. owe compared with what it owns?
ORIC Pharmaceuticals, Inc. owes $0.06 for every $1 it owns (balance sheet Jun 2026), which is low.
What is ORIC Pharmaceuticals, Inc.'s Positivity rank?
ORIC Pharmaceuticals, Inc. is ranked #5,385 of 6,774 companies globally and #2,919 of 4,000 in United States on PositoAI, with a Positivity Score of 17,542.
Does ORIC Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for ORIC Pharmaceuticals, Inc..
Where can I read the latest news about ORIC Pharmaceuticals, Inc.?
Recent headlines about ORIC Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does ORIC Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of ORIC Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.